BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36599091)

  • 1. Photochemical Fingerprinting Is a Sensitive Probe for the Detection of Synthetic Cannabinoid Receptor Agonists; toward Robust Point-of-Care Detection.
    Andrews RC; May B; Hernández FJ; Cozier GE; Townsend PA; Sutcliffe OB; Haines TSF; Freeman TP; Scott J; Husbands SM; Blagbrough IS; Bowman RW; Lewis SE; Grayson MN; Crespo-Otero R; Carbery DR; Pudney CR
    Anal Chem; 2023 Jan; 95(2):703-713. PubMed ID: 36599091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting.
    May B; Naqi HA; Tipping M; Scott J; Husbands SM; Blagbrough IS; Pudney CR
    Anal Chem; 2019 Oct; 91(20):12971-12979. PubMed ID: 31580647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
    Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
    Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic cannabinoid receptor agonists are monoamine oxidase-A selective inhibitors.
    Hindson SA; Andrews RC; Danson MJ; van der Kamp MW; Manley AE; Sutcliffe OB; Haines TSF; Freeman TP; Scott J; Husbands SM; Blagbrough IS; Anderson JLR; Carbery DR; Pudney CR
    FEBS J; 2023 Jun; 290(12):3243-3257. PubMed ID: 36708234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding more "spice" to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists.
    Alam RM; Keating JJ
    Drug Test Anal; 2020 Mar; 12(3):297-315. PubMed ID: 31854124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale evaluation of ion mobility spectrometry for the rapid detection of synthetic cannabinoid receptor agonists in infused papers in prisons.
    Norman C; McKirdy B; Walker G; Dugard P; NicDaéid N; McKenzie C
    Drug Test Anal; 2021 Mar; 13(3):644-663. PubMed ID: 33058556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
    Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
    Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations.
    Norman C; Halter S; Haschimi B; Acreman D; Smith J; Krotulski AJ; Mohr ALA; Logan BK; NicDaéid N; Auwärter V; McKenzie C
    Drug Test Anal; 2021 Apr; 13(4):841-852. PubMed ID: 33463894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons.
    Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C
    Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
    Grafinger KE; Cannaert A; Ametovski A; Sparkes E; Cairns E; Banister SD; Auwärter V; Stove CP
    Drug Test Anal; 2021 Jul; 13(7):1402-1411. PubMed ID: 33769699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
    Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
    Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.
    Banister SD; Connor M
    Handb Exp Pharmacol; 2018; 252():165-190. PubMed ID: 29980914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of the pyrazole-carrying synthetic cannabinoid receptor agonist 5F-3,5-AB-PFUPPYCA and its structural analogs.
    Deventer MH; Norman C; Reid R; McKenzie C; Nic Daéid N; Stove CP
    Forensic Sci Int; 2023 Feb; 343():111565. PubMed ID: 36640535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.
    McQuade D; Hudson S; Dargan PI; Wood DM
    Eur J Clin Pharmacol; 2013 Mar; 69(3):373-6. PubMed ID: 22936123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights.
    Malaca S; Busardò FP; Nittari G; Sirignano A; Ricci G
    Curr Pharm Des; 2022; 28(32):2603-2617. PubMed ID: 34781870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
    Wilson CD; Hiranita T; Fantegrossi WE
    Drug Alcohol Depend; 2022 Jul; 236():109468. PubMed ID: 35643039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre.
    Cairns R; Brown JA; Gunja N; Buckley NA
    Int J Drug Policy; 2017 May; 43():74-82. PubMed ID: 28343112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Cross-Reactive Antibodies for the Identification and Treatment of Synthetic Cannabinoid Receptor Agonist Toxicity.
    Worob A; Wenthur CJ
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narrative Review of the Pharmacodynamics, Pharmacokinetics, and Toxicities of Illicit Synthetic Cannabinoid Receptor Agonists.
    Lea Houston M; Morgan J; Kelso C
    Mini Rev Med Chem; 2024; 24(1):92-109. PubMed ID: 37190813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Walking the nitrogen around the ring": Chemical synthesis and spectroscopic characterization of novel 4-, 5-, 6-, and 7-azaindazole analogs of the synthetic cannabinoid receptor agonist MDMB-PINACA.
    Alam RM; Keating JJ
    Drug Test Anal; 2022 Feb; 14(2):277-297. PubMed ID: 34654062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.